Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Emergency Administration of Epinephrine Amendments
Number
S.B. 108 (2017GS)
Sponsor
Sen. Shiozawa, B.
Final action
Governor Signed 3/17/2017
Outcome
Became law — signed by Gov. Gary R. Herbert

Summary

This bill amends the Emergency Injection for Anaphylactic Reaction Act.

What it does

  • This bill:
  • amends the definition of epinephrine auto-injector to allow the use of more than one manufacturer of a device.

Every vote on this bill

1/31/2017Senate Comm - Favorable Recommendation
Senate Health and Human Services Committee
5 0 3not eligible / no record
2/15/2017Senate/ passed 2nd reading
Senate 3rd Reading Calendar
26 0 3not eligible / no record
2/17/2017Senate/ passed 3rd reading
Clerk of the House
26 0 3not eligible / no record
2/27/2017House Comm - Favorable Recommendation
House Health and Human Services Committee
10 0 2YEA
2/27/2017House Comm - Consent Calendar Recommendation
House Health and Human Services Committee
10 0 2YEA
3/2/2017House/ passed 3rd reading
House Speaker
66 0 9YEA

Bill text

introduced version · official source
EMERGENCY ADMINISTRATION OF EPINEPHRINE
AMENDMENTS
GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Brian E. Shiozawa
House Sponsor: 
 Edward H. Redd
LONG TITLE
General Description:
This bill amends the Emergency Injection for Anaphylactic Reaction Act.
Highlighted Provisions:
This bill:
▸ amends the definition of epinephrine auto-injector to allow the use of more than one
manufacturer of a device.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
26-41-102
, as last amended by Laws of Utah 2015, Chapter 332
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
26-41-102
 is amended to read:
26-41-102.
Definitions.
As used in this chapter:
(1) "Anaphylaxis" means a potentially life-threatening hypersensitivity to a substance.
(a) Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty
breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(b) Causes of anaphylaxis may include insect sting, food allergy, drug reaction, and
exercise.
(2) "Epinephrine auto-injector" means a 
portable,
 disposable drug delivery [
system
with a spring-activated concealed needle that is designed for emergency administration of
epinephrine to provide rapid, convenient first-aid for persons
] 
device that contains a measured,
single dose of epinephrine that is used to treat a person
 suffering a potentially fatal anaphylactic
reaction.
(3) "Qualified adult" means a person who:
(a) is 18 years of age or older; and
(b) has successfully completed the training program established in Section 
26-41-104
.
(4) "Qualified entity":
(a) means a facility or organization that employs, contracts with, or has a similar
relationship with a qualified adult who is likely to have contact with another person who may
experience anaphylaxis; and
(b) includes:
(i) recreation camps;
(ii) an education facility, school, or university;
(iii) a day care facility;
(iv) youth sports leagues;
(v) amusement parks;
(vi) food establishments;
(vii) places of employment; and
(viii) recreation areas.
Legislative Review Note
Office of Legislative Research and General Counsel